Sponsored
What is Leqembi? The first Alzheimer’s treatment approved today in Saudi Arabia
Posted
Saudi Arabia’s SFDA has approved Leqembi (lecanemab), the Kingdom’s first Alzheimer’s treatment. This innovative drug slows disease progression by targeting beta-amyloid plaques, protein clumps that disrupt brain cell communication. Approved for patients with mild symptoms and specific genetic profiles, Leqembi requires careful monitoring to manage side effects, marking a major step forward in Alzheimer’s care through advanced biotechnology.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Another blow for Brazil! US slaps 50% tariff to safeguard American interests; cites Bolsonaro's prosecution as economic emergency
Donald Trump has escalated tensions with Brazil by imposing 50% tariffs, citing an economic...